Related Experiment Video
Updated: Mar 14, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
11.8K
Analytical Issues with Natriuretic Peptides - has this been Overly Simplified?
Alexander G Semenov1, Alexey G Katrukha1
1HyTest Ltd. , Turku, Finland.
EJIFCC
|September 30, 2016
Summary
Natriuretic peptides (NPs) are valuable cardiac biomarkers, but their complex forms require deeper understanding. Accurate measurement and interpretation are crucial for effective cardiovascular disease diagnostics.
Area of Science:
- Biochemistry
- Cardiology
- Biomarker Discovery
Background:
- Natriuretic peptides (NPs) have been recognized as cardiac biomarkers for over 20 years.
- Their diagnostic and prognostic utility in myocardial function is well-established.
- However, a comprehensive understanding of NP biochemistry and circulating forms remains incomplete.
Purpose of the Study:
- To review recent advancements in understanding the complexity of the natriuretic peptide system.
- To discuss analytical challenges associated with NP measurements.
- To explore new diagnostic and research horizons for NPs in cardiovascular disease.
Main Methods:
- Literature review of recent studies on natriuretic peptides.
- Analysis of the biochemical complexity and diversity of circulating NP forms.
- Discussion of analytical issues in plasma NP quantification.
Main Results:
- The diversity of circulating NP forms complicates accurate plasma measurements.
- A simplistic interpretation of elevated NPs for heart failure severity is insufficient.
- Deeper insights into the NP system are necessary for accurate clinical interpretation.
Conclusions:
- Despite extensive use, the full potential of NPs as biomarkers is not yet realized.
- Addressing the complexity of NP biochemistry and measurement is key for advancing cardiovascular diagnostics.
- Further research is needed to refine NP analysis and interpretation in clinical practice.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.7K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.7K
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
684
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
684
01:29Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.4K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K
01:17Hormonal Regulation of Blood Pressure
7.1K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.1K
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K